These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypertension in end-stage renal disease: different measures and their prognostic significance. Hörl WH Nephrol Dial Transplant; 2010 Oct; 25(10):3161-6. PubMed ID: 20685828 [TBL] [Abstract][Full Text] [Related]
4. Blood and hypertension: the damage of too much pressure. Casey G Nurs N Z; 2011 Sep; 17(8):26-31. PubMed ID: 22096822 [No Abstract] [Full Text] [Related]
5. Role of sodium and volume in the pathogenesis of hypertension in hemodialysis. Wilson J; Shah T; Nissenson AR Semin Dial; 2004; 17(4):260-4. PubMed ID: 15250914 [TBL] [Abstract][Full Text] [Related]
6. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients. Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281 [TBL] [Abstract][Full Text] [Related]
7. Drug therapy for hypertension in hemodialysis patients. Hörl MP; Hörl WH Semin Dial; 2004; 17(4):288-94. PubMed ID: 15250920 [TBL] [Abstract][Full Text] [Related]
9. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study]. Poch E; Martinez X; Rodrigo JA; Tovar JL; Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899 [TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
11. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function. Neutel JM J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263 [TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. Portolés J; López-Gómez JM; Aljama P Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011 [TBL] [Abstract][Full Text] [Related]
13. Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment. Morse SA; Dang A; Thakur V; Zhang R; Reisin E Am J Med Sci; 2003 Apr; 325(4):194-201. PubMed ID: 12695724 [TBL] [Abstract][Full Text] [Related]
14. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications. Blankestijn PJ; Ligtenberg G Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915 [TBL] [Abstract][Full Text] [Related]
15. Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations. Van Buren PN; Inrig JK Pediatr Nephrol; 2012 Mar; 27(3):339-50. PubMed ID: 21286758 [TBL] [Abstract][Full Text] [Related]
16. Drug therapy for hypertension in hemodialysis patients. Hörl MP; Tepel M Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894 [TBL] [Abstract][Full Text] [Related]
17. [Hypertension in patients with chronic renal disease]. Laville M Rev Prat; 2004 Mar; 54(6):641-5. PubMed ID: 15222616 [TBL] [Abstract][Full Text] [Related]
18. Blood pressure targets and pharmacotherapy for hypertensive patients on hemodialysis. Maruyama T; Takashima H; Abe M Expert Opin Pharmacother; 2020 Jul; 21(10):1219-1240. PubMed ID: 32281890 [TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive drugs for therapy of hypertension due to long-term hemodialysis]. Kikawada R; Tsuyusaki T Nihon Rinsho; 1991 Dec; 49 Suppl():702-8. PubMed ID: 1687286 [No Abstract] [Full Text] [Related]
20. Pathogenesis and management of intradialytic hypertension. Dousdampanis P; Trigka K; Giannopoulos A; Fourtounas C Curr Hypertens Rev; 2014; 10(3):171-6. PubMed ID: 25563732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]